{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
NCT03729596: Phase 1/Phase 2 Interventional Terminated Squamous Cell Carcinoma of Head and Neck
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:abrezekimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04702880: Phase 2 Interventional Active, not recruiting Extensive-stage Small Cell Lung Cancer
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03989362: Phase 2 Interventional Completed Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04097821: Phase 1/Phase 2 Interventional Completed Myelofibrosis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01405196: Phase 2 Interventional Completed Lupus Erythematosus, Systemic
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03188666: Phase 2 Interventional Completed Fibrodysplasia Ossificans Progressiva
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:crebankitug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02817633: Phase 1 Interventional Recruiting Neoplasms
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04557020: Phase 3 Interventional Recruiting Nasopharyngeal Carcinoma
(2020)
Source URL:
Class:
PROTEIN
